Injective vs Anoma — how do they compare? Injective trades at Rp94,507 (market cap Rp9,29T, Rp1,82T 24h volume), while Anoma trades at Rp212.36 (market cap Rp533,17M, Rp93,13M 24h volume). The key difference: Injective is far larger — about 17424.1× Anoma's market cap, and Anoma's supply is capped (2,5B / 10B XAN (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Anoma for 4 Days on average.
| INJ | XAN | |
|---|---|---|
Market Cap | Rp9,29T | Rp533,17M |
Volume (24h) | Rp1,82T | Rp93,13M |
Circulating Supply | 100M INJ | 2,5B / 10B XAN (25%) |
Typical Hold Time | 36 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Anoma (XAN) is trading at Rp216.88 with a market cap of Rp537.06 million, showing bullish technical signals with strong moving average support and neutral oscillators. The token has 25% circulating supply (2.5M/10M max) with short 4-day average hold time. Current price sits near pivot point Rp208 with resistance at Rp226 and support at Rp190. Technical indicators show bullish momentum with ADX signals confirming trend strength.
Overall outlook remains cautiously optimistic given strong technical signals, but limited fundamental developments and low market cap present both opportunity for growth and significant volatility risk. Investors should monitor exchange liquidity and broader crypto market sentiment while being aware of the token's early-stage adoption profile.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Anoma is a decentralized operating system that enables developers to build a single app that can run on any blockchain. Its intent-centric architecture simplifies infrastructure complexity, improving development efficiency and user experience. Anoma supports a unified app layer that brings Web3 app functionality closer to Web2 usability.
Read more on XAN →